These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
|
|||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
|||||||
|
|
||||||||
|
|
||||||||
|
|
|
|
||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | ||||||||||||
| Smaller reporting company |
|
Emerging growth company |
|
||||||||||||||
| Page | |||||||||||
| PART I. | |||||||||||
| Item 1. | |||||||||||
| Item 2. | |||||||||||
| Item 3. | |||||||||||
| Item 4. | |||||||||||
| PART II. | |||||||||||
| Item 1. | |||||||||||
| Item 1A. | |||||||||||
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
and Issuer Repurchases of Equity Securities
|
||||||||||
| Item 5 | |||||||||||
| Item 6. | |||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| Sep 30, 2025 | Sep 30, 2024 |
Sep 30,
2025 |
Sep 30, 2024 | |||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||
|
Earned Premiums
1
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net Investment Income |
|
|
|
|
||||||||||||||||||||||
| Other Income |
|
|
|
|
||||||||||||||||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net Realized Investment Gains |
|
|
|
|
||||||||||||||||||||||
| Impairment Losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total Revenues |
|
|
|
|
||||||||||||||||||||||
| Expenses: | ||||||||||||||||||||||||||
|
Policyholders’ Benefits and Incurred Losses and Loss Adjustment Expenses
2
|
|
|
|
|
||||||||||||||||||||||
| Insurance and Other Expenses |
|
|
|
|
||||||||||||||||||||||
| Interest Expense |
|
|
|
|
||||||||||||||||||||||
| Total Expenses |
|
|
|
|
||||||||||||||||||||||
| (Loss) Income before Income Taxes |
(
|
|
|
|
||||||||||||||||||||||
| Income Tax (Benefit) Expense |
(
|
|
|
|
||||||||||||||||||||||
| Net (Loss) Income |
(
|
|
|
|
||||||||||||||||||||||
| Less: Net Loss attributable to Noncontrolling Interest |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation per Unrestricted Share:
|
||||||||||||||||||||||||||
| Basic | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Diluted | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
Includes a remeasurement loss related to the deferred profit liability within the Life insurance business of $
|
||||||||||||||||||||||||||
|
2
Includes a remeasurement gain of $
|
||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
|
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30, 2024 | |||||||||||||||||||||||
|
Net (Loss) Income
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other Comprehensive Income Before Income Taxes | ||||||||||||||||||||||||||
| Changes in Unrealized Gains (Losses) on Investment Securities with: | ||||||||||||||||||||||||||
| No Credit Losses Recognized in Condensed Consolidated Statements of (Loss) Income |
|
|
|
|
||||||||||||||||||||||
| Credit Losses Recognized in Condensed Consolidated Statements of (Loss) Income |
(
|
|
|
(
|
||||||||||||||||||||||
| Change in Unrecognized Postretirement Benefit Costs |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Gain on Cash Flow Hedges
|
|
|
|
|
||||||||||||||||||||||
| Change in Discount Rate on Future Life Policyholder Benefits |
(
|
(
|
(
|
|
||||||||||||||||||||||
| Other Comprehensive Income Before Income Taxes |
|
|
|
|
||||||||||||||||||||||
| Other Comprehensive Income Tax Expense |
|
|
|
|
||||||||||||||||||||||
| Other Comprehensive Income, Net of Taxes |
|
|
|
|
||||||||||||||||||||||
| Total Comprehensive Income |
|
|
|
|
||||||||||||||||||||||
| Less: Net Loss attributable to Noncontrolling Interest |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Less: Other Comprehensive Income attributable to Noncontrolling Interest
|
|
|
|
|
||||||||||||||||||||||
| Less: Total Comprehensive Loss attributable to Noncontrolling Interest |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Comprehensive Income attributable to Kemper Corporation
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Sep 30,
2025 |
Dec 31, 2024 | ||||||||||
| Assets: | |||||||||||
| Investments: | |||||||||||
|
Fixed Maturities at Fair Value (Amortized Cost: 2025 - $
Allowance for Credit Losses: 2025 - $
|
$ |
|
$ |
|
|||||||
|
Equity Securities at Fair Value (Cost: 2025 - $
|
|
|
|||||||||
| Equity Method Limited Liability Investments |
|
|
|||||||||
| Short-term Investments at Cost which Approximates Fair Value |
|
|
|||||||||
|
Company-Owned Life Insurance
|
|
|
|||||||||
|
Loans to Policyholders
|
|
|
|||||||||
| Other Investments |
|
|
|||||||||
| Total Investments |
|
|
|||||||||
| Cash |
|
|
|||||||||
|
Receivables from Policyholders (Allowance for Credit Losses: 2025 - $
|
|
|
|||||||||
| Other Receivables |
|
|
|||||||||
| Deferred Policy Acquisition Costs |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Current Income Tax Assets |
|
|
|||||||||
| Deferred Income Tax Assets |
|
|
|||||||||
| Other Assets |
|
|
|||||||||
|
Assets of Consolidated Variable Interest Entity
|
|||||||||||
|
Fixed Maturities at Fair Value (Amortized Cost: 2025 - $
|
|
|
|||||||||
| Short-term Investments at Cost which Approximates Fair Value |
|
|
|||||||||
| Cash |
|
|
|||||||||
|
Receivables from Policyholders
|
|
|
|||||||||
|
Other Receivables
|
|
|
|||||||||
| Deferred Policy Acquisition Costs |
|
|
|||||||||
| Deferred Income Tax Assets |
|
|
|||||||||
| Total Assets | $ |
|
$ |
|
|||||||
|
Sep 30,
2025 |
Dec 31, 2024 | ||||||||||
| Liabilities and Shareholders’ Equity: | |||||||||||
| Insurance Reserves: | |||||||||||
| Life and Health | $ |
|
$ |
|
|||||||
| Property and Casualty |
|
|
|||||||||
| Total Insurance Reserves |
|
|
|||||||||
| Unearned Premiums |
|
|
|||||||||
| Policyholder Obligations |
|
|
|||||||||
| Deferred Income Tax Liabilities |
|
|
|||||||||
| Accrued Expenses and Other Liabilities |
|
|
|||||||||
|
Long-term Debt, Current, at Amortized Cost
|
|
|
|||||||||
|
Long-term Debt, Non-Current, at Amortized Cost
|
|
|
|||||||||
|
Liabilities of Consolidated Variable Interest Entity
|
|||||||||||
| Insurance Reserves |
|
|
|||||||||
| Unearned Premiums |
|
|
|||||||||
| Accrued Expenses and Other Liabilities |
|
|
|||||||||
| Total Liabilities |
|
|
|||||||||
| Kemper Corporation Shareholders’ Equity: | |||||||||||
|
Common Stock, $
|
|
|
|||||||||
| Paid-in Capital |
|
|
|||||||||
| Retained Earnings |
|
|
|||||||||
| Accumulated Other Comprehensive Loss |
(
|
(
|
|||||||||
| Total Kemper Corporation Shareholders’ Equity |
|
|
|||||||||
| Noncontrolling Interest |
(
|
(
|
|||||||||
| Total Shareholders’ Equity |
|
|
|||||||||
| Total Liabilities and Shareholders’ Equity | $ |
|
$ |
|
|||||||
| Nine Months Ended | |||||||||||
|
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||
| Cash Flows from Operating Activities: | |||||||||||
|
Net Income
|
$ |
|
$ |
|
|||||||
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities | |||||||||||
| Net Realized Investment Gains |
(
|
(
|
|||||||||
| Impairment Losses |
|
|
|||||||||
|
Depreciation, Amortization, and Impairments of Property, Equipment, Software and Intangible Assets Acquired
|
|
|
|||||||||
| Settlement Related to Defined Benefit Pension Plan |
|
(
|
|||||||||
| Change in Accumulated Undistributed Earnings of Equity Method Limited Liability Investments |
|
|
|||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
|
|
|||||||||
| Changes in: | |||||||||||
| Receivables from Policyholders |
(
|
(
|
|||||||||
| Reinsurance Recoverables |
|
|
|||||||||
| Deferred Policy Acquisition Costs |
(
|
(
|
|||||||||
| Insurance Reserves |
|
(
|
|||||||||
| Unearned Premiums |
|
(
|
|||||||||
| Income Taxes |
|
|
|||||||||
| Other |
(
|
(
|
|||||||||
| Net Cash Provided by Operating Activities |
|
|
|||||||||
| Cash Flows from Investing Activities: | |||||||||||
| Proceeds from the Sales, Calls and Maturities of Fixed Maturities |
|
|
|||||||||
| Proceeds from the Sales or Paydowns of Investments: | |||||||||||
| Equity Securities |
|
|
|||||||||
| Real Estate Investments |
|
|
|||||||||
| Mortgage Loans |
|
|
|||||||||
| Other Investments |
|
|
|||||||||
| Purchases of Investments: | |||||||||||
| Fixed Maturities |
(
|
(
|
|||||||||
| Equity Securities |
(
|
(
|
|||||||||
| Real Estate Investments |
(
|
(
|
|||||||||
| Mortgage Loans |
(
|
(
|
|||||||||
| Other Investments |
(
|
(
|
|||||||||
| Net Sales (Purchases) of Short-term Investments |
|
(
|
|||||||||
| Acquisition of Software and Long-lived Assets |
(
|
(
|
|||||||||
| Settlement Proceeds from Company-Owned Life Insurance |
|
|
|||||||||
| Other |
|
|
|||||||||
| Net Cash Provided by (Used in) Investing Activities |
|
(
|
|||||||||
| Nine Months Ended | |||||||||||
|
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||
|
Net Cash Provided by (Used in) Investing Activities (Carryforward from page 8)
|
|
(
|
|||||||||
| Cash Flows from Financing Activities: | |||||||||||
| Repayment of Long-term Debt |
(
|
|
|||||||||
| Proceeds from Policyholder Contract Obligations |
|
|
|||||||||
| Repayment of Policyholder Contract Obligations |
(
|
(
|
|||||||||
| Proceeds from Shares Issued under Employee Stock Purchase Plan |
|
|
|||||||||
| Common Stock Repurchases |
(
|
(
|
|||||||||
| Dividends Paid |
(
|
(
|
|||||||||
| Other |
(
|
(
|
|||||||||
| Net Cash Used in Financing Activities |
(
|
(
|
|||||||||
|
Net increase (decrease) in cash
1
|
|
(
|
|||||||||
|
Cash, Beginning of Year
1
|
|
|
|||||||||
|
Cash, End of Period
1
|
$ |
|
$ |
|
|||||||
|
1
Includes amounts attributable to Kemper Reciprocal reported as non-controlling interest.
|
|||||||||||
| Nine Months Ended | |||||||||||
|
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||
| Cash (paid) received during the year for: | |||||||||||
| Interest | $ |
(
|
$ |
(
|
|||||||
| Taxes |
(
|
(
|
|||||||||
| Operating Leases |
(
|
(
|
|||||||||
| Non-Cash Activities: | |||||||||||
| Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities | $ |
|
$ |
|
|||||||
| Three Months Ended September 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||
|
Number of
Shares |
Common
Stock |
Paid-in
Capital |
Retained
Earnings |
Accumulated Other Comprehensive (Loss) Income | Noncontrolling Interest |
Total
Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||||
|
Balance, June 30, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Net Loss | — | — | — |
(
|
— |
(
|
(
|
|||||||||||||||||||||||||||||||||||||
|
Other Comprehensive Income, Net of Taxes (Note 12)
|
— | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||
|
Cash Dividends and Dividend Equivalents to Shareholders ($
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Repurchases of Common Stock (Note 13)
|
(
|
(
|
(
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Shares Issued Under Employee Stock Purchase Plan (Note 13)
|
— |
(
|
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Compensation Cost | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Awards, Net of Shares Exchanged | — | — |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||
| Other Changes in Non-Controlling Interest | — | — | — | — | — |
|
|
|||||||||||||||||||||||||||||||||||||
|
Balance, September 30, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Three Months Ended September 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
|
Number of
Shares |
Common
Stock |
Paid-in
Capital |
Retained
Earnings |
Accumulated Other Comprehensive (Loss) Income | Noncontrolling Interest |
Total
Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||||
|
Balance, June 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Net Income | — | — | — |
|
— |
(
|
|
|||||||||||||||||||||||||||||||||||||
|
Other Comprehensive Income, Net of Taxes (Note 12)
|
— | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||
|
Cash Dividends and Dividend Equivalents to Shareholders ($
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Repurchases of Common Stock (Note 13)
|
(
|
— |
(
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Shares Issued Under Employee Stock Purchase Plan (Note 13)
|
— | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Compensation Cost | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Awards, Net of Shares Exchanged | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Other Changes in Non-Controlling Interest | — | — | — | — | — |
|
|
|||||||||||||||||||||||||||||||||||||
|
Balance, September 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||
|
Number of
Shares |
Common
Stock |
Paid-in
Capital |
Retained
Earnings |
Accumulated Other Comprehensive (Loss) Income | Noncontrolling Interest |
Total
Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||||
|
Balance, December 31, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Net Income | — | — | — |
|
— |
(
|
|
|||||||||||||||||||||||||||||||||||||
|
Other Comprehensive Income, Net of Taxes (Note 12)
|
— | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||
|
Cash Dividends and Dividend Equivalents to Shareholders ($
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Repurchases of Common Stock (Note 13)
|
(
|
(
|
(
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Shares Issued Under Employee Stock Purchase Plan (Note 13)
|
— |
|
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Compensation Cost | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Awards, Net of Shares Exchanged |
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||
| Other Changes in Non-Controlling Interest | — | — | — | — | — |
|
|
|||||||||||||||||||||||||||||||||||||
|
Balance, September 30, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
|
Number of
Shares |
Common
Stock |
Paid-in
Capital |
Retained
Earnings |
Accumulated Other Comprehensive (Loss) Income | Noncontrolling Interest |
Total
Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||||
|
Balance, December 31, 2023
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Net Income | — | — | — |
|
— |
(
|
|
|||||||||||||||||||||||||||||||||||||
|
Other Comprehensive Income, Net of Taxes (Note 12)
|
— | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||
|
Cash Dividends and Dividend Equivalents to Shareholders ($
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Repurchases of Common Stock (Note 13)
|
(
|
— |
(
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||
|
Shares Issued Under Employee Stock Purchase Plan (Note 13)
|
— | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Compensation Cost | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||
| Equity-based Awards, Net of Shares Exchanged |
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||
| Other Changes in Non-Controlling Interest | — | — | — | — | — |
|
|
|||||||||||||||||||||||||||||||||||||
|
Balance, September 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions, except per share amounts) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Shares in Thousands | ||||||||||||||||||||||||||
|
Weighted-average Unrestricted Shares Outstanding
|
|
|
|
|
||||||||||||||||||||||
|
Equity-based Compensation Equivalent Shares
|
|
|
|
|
||||||||||||||||||||||
|
Weighted-average Unrestricted Shares and Equivalent Shares Outstanding Assuming Dilution
|
|
|
|
|
||||||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation per Unrestricted Share:
|
||||||||||||||||||||||||||
| (Per Unrestricted Share in Whole Dollars) | ||||||||||||||||||||||||||
|
Basic Net (Loss) Income Per Unrestricted Share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Diluted Net (Loss) Income Per Unrestricted Share
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
(
Dollars in Millions)
|
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Segment Assets: | ||||||||||||||
|
Specialty Property & Casualty Insurance
1
|
$ |
|
$ |
|
||||||||||
| Life Insurance |
|
|
||||||||||||
| Total Segment Assets |
|
|
||||||||||||
| Corporate and Other |
|
|
||||||||||||
| Non-Core Operations |
|
|
||||||||||||
|
Total Assets
1
|
$ |
|
$ |
|
||||||||||
|
1
Includes $
|
||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Specialty Property & Casualty Insurance: | ||||||||||||||||||||||||||
| Personal Automobile | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Commercial Automobile |
|
|
|
|
||||||||||||||||||||||
|
Total Specialty Property & Casualty Insurance
|
|
|
|
|
||||||||||||||||||||||
| Life Insurance: | ||||||||||||||||||||||||||
| Life |
|
|
|
|
||||||||||||||||||||||
| Accident and Health |
|
|
|
|
||||||||||||||||||||||
| Property |
|
|
|
|
||||||||||||||||||||||
|
Total Life Insurance
|
|
|
|
|
||||||||||||||||||||||
| Total Segment Earned Premiums |
|
|
|
|
||||||||||||||||||||||
| Non-Core Operations |
|
|
|
|
||||||||||||||||||||||
| Total Earned Premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Segment Revenues: | ||||||||||||||||||||||||||
| Specialty Property & Casualty Insurance: | ||||||||||||||||||||||||||
| Earned Premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net Investment Income |
|
|
|
|
||||||||||||||||||||||
| Other Income |
|
|
|
|
||||||||||||||||||||||
| Total Specialty Property & Casualty Insurance |
|
|
|
|
||||||||||||||||||||||
| Life Insurance: | ||||||||||||||||||||||||||
| Earned Premiums |
|
|
|
|
||||||||||||||||||||||
| Net Investment Income |
|
|
|
|
||||||||||||||||||||||
| Other Income |
|
|
|
|
||||||||||||||||||||||
| Total Life Insurance |
|
|
|
|
||||||||||||||||||||||
| Total Segment Revenues |
|
|
|
|
||||||||||||||||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net Realized Investment Gains |
|
|
|
|
||||||||||||||||||||||
| Impairment Losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Non-Core Operations |
|
|
|
|
||||||||||||||||||||||
|
Other
|
|
|
|
|
||||||||||||||||||||||
| Total Revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
|
(Dollars in Millions)
|
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Segment Expenses: | ||||||||||||||||||||||||||
| Specialty Property & Casualty Insurance: | ||||||||||||||||||||||||||
| Current Year | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Catastrophe Losses and LAE |
|
|
|
|
||||||||||||||||||||||
| Prior Years | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE |
|
(
|
|
|
||||||||||||||||||||||
| Catastrophe Losses and LAE |
|
|
|
|
||||||||||||||||||||||
| Total Incurred Losses and LAE |
|
|
|
|
||||||||||||||||||||||
|
Policy Acquisition Costs
1
|
|
|
|
|
||||||||||||||||||||||
|
Business Unit Operating Costs
2
|
|
|
|
|
||||||||||||||||||||||
|
Corporate Overhead Costs
3
|
|
|
|
|
||||||||||||||||||||||
| Total Insurance Expenses |
|
|
|
|
||||||||||||||||||||||
| Income Tax Expense |
|
|
|
|
||||||||||||||||||||||
| Total Specialty Property & Casualty Insurance |
|
|
|
|
||||||||||||||||||||||
| Life Insurance: | ||||||||||||||||||||||||||
| Policyholders’ Benefits and Incurred Losses and LAE |
|
|
|
|
||||||||||||||||||||||
|
Policy Acquisition Costs
1
|
|
|
|
|
||||||||||||||||||||||
|
Business Unit Operating Costs
2
|
|
|
|
|
||||||||||||||||||||||
|
Corporate Overhead Costs
3
|
|
|
|
|
||||||||||||||||||||||
| Total Insurance Expenses |
|
|
|
|
||||||||||||||||||||||
| Income Tax Expense |
|
|
|
|
||||||||||||||||||||||
| Total Life Insurance |
|
|
|
|
||||||||||||||||||||||
| Total Segment Expenses | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
Policy acquisition costs primarily represents commissions and premium taxes that are incurred by the Company as a result of underwriting insurance policies and reflect the impacts of deferral and amortization of certain of these costs in accordance with the Company’s accounting policies.
|
||||||||||||||||||||||||||
|
2
Business unit operating costs are general expenses incurred by the Company's segments as part of ongoing operations and includes employee, IT, and facilities expenses.
|
||||||||||||||||||||||||||
|
3
Corporate overhead costs represents general expenses and other shared service expenses which are allocated across the Company.
|
||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
|
Segment Adjusted Net Operating Income:
|
||||||||||||||||||||||||||
| Specialty Property & Casualty Insurance | ||||||||||||||||||||||||||
|
Revenues
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Expenses
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Specialty Property & Casualty Insurance Adjusted Net Operating Income
|
|
|
|
|
||||||||||||||||||||||
| Life Insurance | ||||||||||||||||||||||||||
|
Revenues
|
|
|
|
|
||||||||||||||||||||||
|
Expenses
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Life Insurance Adjusted Net Operating Income
|
|
|
|
|
||||||||||||||||||||||
|
Total Segment Adjusted Net Operating Income
|
|
|
|
|
||||||||||||||||||||||
|
Corporate and Other Adjusted Net Operating Loss
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Less: Net Loss attributable to Noncontrolling Interest
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Net Income (Loss) From:
|
||||||||||||||||||||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net Realized Investment Gains |
|
|
|
|
||||||||||||||||||||||
| Impairment Losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Acquisition and Disposition Related Transaction, Integration, Restructuring and Other Costs |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Debt Extinguishment, Pension Settlement and Other Charges |
|
(
|
|
(
|
||||||||||||||||||||||
| Non-Core Operations |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Nine Months Ended | ||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||
| Property and Casualty Insurance Reserves: | ||||||||||||||
| Gross of Reinsurance at Beginning of Year | $ |
|
$ |
|
||||||||||
| Less: Reinsurance Recoverables at Beginning of Year |
|
|
||||||||||||
| Property and Casualty Insurance Reserves, Net of Reinsurance at Beginning of Year |
|
|
||||||||||||
| Incurred Losses and LAE related to: | ||||||||||||||
| Current Year |
|
|
||||||||||||
| Prior Years |
|
|
||||||||||||
| Total Incurred Losses and LAE |
|
|
||||||||||||
| Paid Losses and LAE related to: | ||||||||||||||
| Current Year |
|
|
||||||||||||
| Prior Years |
|
|
||||||||||||
| Total Paid Losses and LAE |
|
|
||||||||||||
| Property and Casualty Insurance Reserves, Net of Reinsurance at End of Period |
|
|
||||||||||||
| Plus: Reinsurance Recoverables at End of Period |
|
|
||||||||||||
| Property and Casualty Insurance Reserves, Gross of Reinsurance at End of Period | $ |
|
$ |
|
||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2025 | Sep 30, 2024 | |||||||||||||||||||||||||
| Present Value of Expected Net Premiums | Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Beginning Balance at Original Discount Rate | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Effect of Changes in Cash Flow Assumptions |
|
|
|
|
|||||||||||||||||||||||||
| Effect of Actual Variances from Expected Experience |
|
(
|
|
|
|||||||||||||||||||||||||
| Adjusted Beginning of Period Balance |
|
|
|
|
|||||||||||||||||||||||||
| Issuances |
|
|
|
|
|||||||||||||||||||||||||
| Interest Accrual |
|
|
|
|
|||||||||||||||||||||||||
| Net Premiums Collected |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Ending Balance at Original Discount Rate |
|
|
|
|
|||||||||||||||||||||||||
| Effect of Changes in Discount Rate Assumptions |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Present Value of Expected Future Policyholder Benefits | Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Beginning Balance at Original Discount Rate | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Effect of Changes in Cash Flow Assumptions |
|
|
|
|
|||||||||||||||||||||||||
| Effect of Actual Variances From Expected Experience |
(
|
(
|
|
|
|||||||||||||||||||||||||
| Adjusted Beginning of Period Balance |
|
|
|
|
|||||||||||||||||||||||||
| Issuances |
|
|
|
|
|||||||||||||||||||||||||
| Interest Accrual |
|
|
|
|
|||||||||||||||||||||||||
| Benefit Payments |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Ending Balance at Original Discount Rate |
|
|
|
|
|||||||||||||||||||||||||
| Effect of Changes in Discount Rate Assumptions |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Net Liability for Future Policyholder Benefits, pre-flooring | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Cumulative impact of flooring the future Policyholder Benefits Reserve |
|
|
|
|
|||||||||||||||||||||||||
| Net Liability for Future Policyholder Benefits, post-flooring |
|
|
|
|
|||||||||||||||||||||||||
| Less: Reinsurance Recoverable |
|
|
|
|
|||||||||||||||||||||||||
| Net Liability for Future Policyholder Benefits, After Reinsurance Recoverable | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Sep 30, 2025 | Sep 30, 2024 | ||||||||||
| Weighted-Average Liability Duration of the Liability for Future Policyholder Benefits (Years) |
|
|
|||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | |||||||||
| Net Liability for Future Policyholder Benefits, post-flooring | $ |
|
$ |
|
|||||||
| Deferred Profit Liability |
|
|
|||||||||
|
Other
1
|
|
|
|||||||||
| Total Life and Health Insurance Reserves | $ |
|
$ |
|
|||||||
|
1
Other primarily consists of Accident and Health and Universal Life reserves
|
|||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | |||||||||
| Expected Future Benefit Payments, undiscounted | $ |
|
$ |
|
|||||||
| Expected Future Gross Premiums, undiscounted | $ |
|
$ |
|
|||||||
| Expected Future Gross Premiums, discounted | $ |
|
$ |
|
|||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2025 | Sep 30, 2024 | ||||||||||||||||||||||
| Gross Premiums or Assessments | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest Expense | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Sep 30, 2025 | Sep 30, 2024 | ||||||||||
| Interest Accretion Rate |
|
% |
|
% | |||||||
| Current Discount Rate |
|
% |
|
% | |||||||
| Nine Months Ended | |||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | |||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
|||||||
| Profits Deferred |
|
|
|||||||||
| Interest Accrual |
|
|
|||||||||
| Amortization |
(
|
(
|
|||||||||
| Effect of Actual Variances from Expected Experience and Other Changes |
|
|
|||||||||
| Balance, End of Period | $ |
|
$ |
|
|||||||
|
Amortized
Cost |
Gross Unrealized | Allowance for Expected Credit Losses | Fair Value | |||||||||||||||||||||||||||||
| (Dollars in Millions) | Gains | Losses | ||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||
| States and Political Subdivisions |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Foreign Governments |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Redeemable Preferred Stocks |
|
|
|
|
|
|||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Other Mortgage- and Asset-backed |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Investments in Fixed Maturities | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||
|
Amortized
Cost |
Gross Unrealized | Allowance for Expected Credit Losses | Fair Value | |||||||||||||||||||||||||||||
| (Dollars in Millions) | Gains | Losses | ||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||
| States and Political Subdivisions |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Foreign Governments |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Redeemable Preferred Stocks |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
|
(
|
(
|
|
|||||||||||||||||||||||||||
| Other Mortgage- and Asset-backed |
|
|
(
|
|
|
|||||||||||||||||||||||||||
| Investments in Fixed Maturities | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||
| (Dollars in Millions) | Amortized Cost | Fair Value | ||||||||||||
| Due in One Year or Less | $ |
|
$ |
|
||||||||||
| Due after One Year to Five Years |
|
|
||||||||||||
| Due after Five Years to Ten Years |
|
|
||||||||||||
| Due after Ten Years |
|
|
||||||||||||
| Mortgage- and Asset-backed Securities Not Due at a Single Maturity Date |
|
|
||||||||||||
| Investments in Fixed Maturities | $ |
|
$ |
|
||||||||||
| Less Than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Fair
Value |
Unrealized
Losses |
Fair
Value |
Unrealized
Losses |
Fair
Value |
Unrealized
Losses |
||||||||||||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| States and Political Subdivisions |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Foreign Governments |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Redeemable Preferred Stocks |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Other Mortgage- and Asset-backed |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Total Fixed Maturities | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Less Than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Fair
Value |
Unrealized
Losses |
Fair
Value |
Unrealized
Losses |
Fair
Value |
Unrealized
Losses |
||||||||||||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| States and Political Subdivisions |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Foreign Governments |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Redeemable Preferred Stocks |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Other Mortgage- and Asset-backed |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| Total Fixed Maturities | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| States and Political Subdivisions | Corporate Bonds and Notes | Total | ||||||||||||||||||
| (Dollars in Millions) | ||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
||||||||||||||
|
Additions for Securities for which No Previous Expected Credit Losses were
Recognized |
|
|
|
|||||||||||||||||
| Reductions Due to Sales |
|
(
|
(
|
|||||||||||||||||
| Net (Decrease) Increase in Allowance on Securities for which Expected Credit Losses were Previously Recognized |
(
|
|
|
|||||||||||||||||
|
Write-Offs Charged Against Allowance
|
|
(
|
(
|
|||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
||||||||||||||
| States and Political Subdivisions | Corporate Bonds and Notes | Total | ||||||||||||||||||
| (Dollars in Millions) | ||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
||||||||||||||
|
Additions for Securities for which No Previous Expected Credit Losses were
Recognized |
|
|
|
|||||||||||||||||
| Reductions Due to Sales |
|
(
|
(
|
|||||||||||||||||
| Net (Decrease) Increase in Allowance on Securities for which Expected Credit Losses were Previously Recognized |
(
|
|
|
|||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
|
Equity Securities at Modified Cost
|
$ |
|
$ |
|
||||||||||
| Real Estate at Depreciated Cost |
|
|
||||||||||||
| Mortgage Loans |
|
|
||||||||||||
|
Alternative Energy Partnership Investments
|
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Total Other Investments | $ |
|
$ |
|
||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Investment Income: | ||||||||||||||||||||||||||
|
Interest on Fixed Maturities
1
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Dividends on Equity Securities Excluding Alternative Investments |
|
|
|
|
||||||||||||||||||||||
| Alternative Investments: | ||||||||||||||||||||||||||
| Equity Method Limited Liability Investments |
|
|
(
|
(
|
||||||||||||||||||||||
| Limited Liability Investments Included in Equity Securities |
|
|
|
|
||||||||||||||||||||||
| Total Alternative Investments |
|
|
|
|
||||||||||||||||||||||
| Short-term Investments |
|
|
|
|
||||||||||||||||||||||
| Loans to Policyholders |
|
|
|
|
||||||||||||||||||||||
| Real Estate |
|
|
|
|
||||||||||||||||||||||
| Company-Owned Life Insurance |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total Investment Income |
|
|
|
|
||||||||||||||||||||||
| Investment Expenses: | ||||||||||||||||||||||||||
| Real Estate |
|
|
|
|
||||||||||||||||||||||
|
Other Investment Expenses
|
|
|
|
|
||||||||||||||||||||||
| Total Investment Expenses |
|
|
|
|
||||||||||||||||||||||
| Net Investment Income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
Reduced by interest expense incurred on FHLB borrowings used for spread lending purposes of $
|
||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||
| Gains on Sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Losses on Sales |
(
|
|
(
|
(
|
||||||||||||||||||||||
|
Losses on Hedging Activity
1
|
|
|
|
(
|
||||||||||||||||||||||
| Equity Securities: | ||||||||||||||||||||||||||
| Gains on Sales |
|
|
|
|
||||||||||||||||||||||
| Losses on Sales |
|
|
|
(
|
||||||||||||||||||||||
|
Other Investments:
|
||||||||||||||||||||||||||
| Gains on Sales |
|
|
|
|
||||||||||||||||||||||
| Losses on Sales |
|
(
|
|
(
|
||||||||||||||||||||||
|
Net Realized Investment Gains
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
Includes Ultra-Long Treasury Future derivative securities which do not qualify for hedge accounting treatment.
|
||||||||||||||||||||||||||
| September 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Estimated Fair Value | Estimated Fair Value | ||||||||||||||||||||||||||||||||||||||||||
| Derivative Instrument | Primary Underlying Risk Exposure | Gross Notional Amount | Assets | Liabilities | Gross Notional Amount | Assets | Liabilities | |||||||||||||||||||||||||||||||||||||
| Derivatives Designated as Hedging Instruments: | ||||||||||||||||||||||||||||||||||||||||||||
| Treasury Futures | Interest Rate Risk | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Beginning of Period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Gains (Losses) Deferred in AOCI |
|
|
(
|
(
|
||||||||||||||||||||||
| Net Change in AOCI with Current Period Hedging Transactions |
|
|
|
|
||||||||||||||||||||||
| Losses Reclassified into Income |
|
|
|
|
||||||||||||||||||||||
| Net Comprehensive (Losses) Gains from Cash Flow Hedges | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Fair Value Measurements | ||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
Significant Other
Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Measured at Net Asset Value | Total Fair Value | |||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| States and Political Subdivisions |
|
|
|
|
|
|||||||||||||||||||||||||||
| Foreign Governments |
|
|
|
|
|
|||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
|
|
|
|
|||||||||||||||||||||||||||
| Redeemable Preferred Stock |
|
|
|
|
|
|||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Mortgage and Asset-backed |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Investments in Fixed Maturities |
|
|
|
|
|
|||||||||||||||||||||||||||
| Equity Securities at Fair Value: | ||||||||||||||||||||||||||||||||
| Preferred Stocks: | ||||||||||||||||||||||||||||||||
| Finance, Insurance and Real Estate |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Industries |
|
|
|
|
|
|||||||||||||||||||||||||||
| Common Stocks: | ||||||||||||||||||||||||||||||||
| Finance, Insurance and Real Estate |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Industries |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Equity Interests: | ||||||||||||||||||||||||||||||||
| Exchange Traded Funds |
|
|
|
|
|
|||||||||||||||||||||||||||
| Limited Liability Companies and Limited Partnerships |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Investments in Equity Securities at Fair Value |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Investments: | ||||||||||||||||||||||||||||||||
| Derivative Instrument Classified as Cash Flow Hedge |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Fair Value Measurements | ||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
Significant Other
Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Measured at Net Asset Value | Total Fair Value | |||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| States and Political Subdivisions |
|
|
|
|
|
|||||||||||||||||||||||||||
| Foreign Governments |
|
|
|
|
|
|||||||||||||||||||||||||||
| Corporate Securities: | ||||||||||||||||||||||||||||||||
| Bonds and Notes |
|
|
|
|
|
|||||||||||||||||||||||||||
| Redeemable Preferred Stocks |
|
|
|
|
|
|||||||||||||||||||||||||||
| Collateralized Loan Obligations |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Mortgage and Asset-backed |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Investments in Fixed Maturities |
|
|
|
|
|
|||||||||||||||||||||||||||
| Equity Securities at Fair Value: | ||||||||||||||||||||||||||||||||
| Preferred Stocks: | ||||||||||||||||||||||||||||||||
| Finance, Insurance and Real Estate |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Industries |
|
|
|
|
|
|||||||||||||||||||||||||||
| Common Stocks: | ||||||||||||||||||||||||||||||||
| Finance, Insurance and Real Estate |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Industries |
|
|
|
|
|
|||||||||||||||||||||||||||
| Other Equity Interests: | ||||||||||||||||||||||||||||||||
| Exchange Traded Funds |
|
|
|
|
|
|||||||||||||||||||||||||||
| Limited Liability Companies and Limited Partnerships |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Investments in Equity Securities at Fair Value |
|
|
|
|
|
|||||||||||||||||||||||||||
| Total Assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||
| Accrued Expenses and Other Liabilities: | ||||||||||||||||||||||||||||||||
|
Derivative Instruments Designated as Cash Flow Hedges
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
| Total Liabilities | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||
| (Dollars in Millions) | Unobservable Input | Total Fair Value | Range of Unobservable Inputs | Weighted-average Yield | ||||||||||||||||||||||||||||
| Investment-grade | Market Yield | $ |
|
|
% | - |
|
% |
|
% | ||||||||||||||||||||||
| Non-investment-grade: | ||||||||||||||||||||||||||||||||
| Senior Debt | Market Yield |
|
|
- |
|
|
||||||||||||||||||||||||||
| Junior Debt | Market Yield |
|
|
- |
|
|
||||||||||||||||||||||||||
| Other | Various |
|
||||||||||||||||||||||||||||||
| Total Level 3 Fixed Maturity Investments | $ |
|
||||||||||||||||||||||||||||||
| (Dollars in Millions) | Unobservable Input | Total Fair Value | Range of Unobservable Inputs | Weighted-average Yield | ||||||||||||||||||||||||||||
| Investment-grade | Market Yield | $ |
|
|
% | - |
|
% |
|
% | ||||||||||||||||||||||
| Non-investment-grade: | ||||||||||||||||||||||||||||||||
| Senior Debt | Market Yield |
|
|
- |
|
|
||||||||||||||||||||||||||
| Junior Debt | Market Yield |
|
|
- |
|
|
||||||||||||||||||||||||||
| Other | Various |
|
||||||||||||||||||||||||||||||
| Total Level 3 Fixed Maturity Investments | $ |
|
||||||||||||||||||||||||||||||
| Fixed Maturities | Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Corporate
Bonds and Notes |
Foreign Governments
|
States and Political Sub- divisions |
Redeemable
Preferred Stocks |
Collateralized Loan Obligations |
Other Mortgage-
and Asset- backed |
Preferred
and Common Stocks |
Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Total Gains (Losses): | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Condensed Consolidated Statements of (Loss) Income
|
|
|
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Other Comprehensive Income
|
(
|
|
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sales |
(
|
(
|
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 |
|
|
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities | Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Corporate
Bonds and Notes |
States and Political Sub- divisions |
Redeemable
Preferred Stocks |
Collateralized Loan Obligations |
Other Mortgage-
and Asset- backed |
Preferred
and Common Stocks |
Total | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
| Total Gains (Losses): | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Condensed Consolidated Statements of (Loss) Income
|
|
|
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Other Comprehensive Income
|
|
(
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Sales |
(
|
|
|
|
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 |
(
|
|
|
(
|
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities | Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Corporate
Bonds and Notes |
Foreign Governments
|
States and Political Sub- divisions |
Redeemable
Preferred Stocks |
Collateralized Loan Obligations |
Other Mortgage-
and Asset- backed |
Preferred
and Common Stocks |
Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Total Gains (Losses): | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Condensed Consolidated Statements of (Loss) Income
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Other Comprehensive Income
|
(
|
|
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sales |
(
|
(
|
|
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 |
(
|
|
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities | Equity Securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Corporate
Bonds and Notes |
States and Political Sub- divisions |
Redeemable
Preferred Stocks |
Collateralized Loan Obligations |
Other Mortgage-
and Asset- backed |
Preferred
and Common Stocks |
Total | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
| Total Gains (Losses): | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Condensed Consolidated Statements of (Loss) Income
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
Included in Other Comprehensive Income
|
|
(
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Sales |
(
|
|
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Transfers out of Level 3 |
(
|
(
|
(
|
(
|
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) | September 30, 2025 | December 31, 2024 | ||||||||||||||||||||||||
| Asset Class | Fair Value Using NAV | Unfunded Commitments | Fair Value Using NAV | Unfunded Commitments | ||||||||||||||||||||||
| Reported as Equity Method Limited Liability Investments: | ||||||||||||||||||||||||||
| Mezzanine Debt | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Real Estate |
|
|
|
|
||||||||||||||||||||||
| Senior Debt |
|
|
|
|
||||||||||||||||||||||
| Leveraged Buyout |
|
|
|
|
||||||||||||||||||||||
| Secondary Transactions |
|
|
|
|
||||||||||||||||||||||
| Distressed Debt |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total Equity Method Limited Liability Investments |
|
|
|
|
||||||||||||||||||||||
| Reported as Other Equity Interests at Fair Value: | ||||||||||||||||||||||||||
| Mezzanine Debt |
|
|
|
|
||||||||||||||||||||||
| Leveraged Buyout |
|
|
|
|
||||||||||||||||||||||
| Senior Debt |
|
|
|
|
||||||||||||||||||||||
| Distressed Debt |
|
|
|
|
||||||||||||||||||||||
| Growth Equity |
|
|
|
|
||||||||||||||||||||||
| Secondary Transactions |
|
|
|
|
||||||||||||||||||||||
|
Real Estate
|
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total Reported as Other Equity Interests at Fair Value |
|
|
|
|
||||||||||||||||||||||
| Reported as Equity Securities at Modified Cost: | ||||||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total Reported as Equity Securities at Modified Cost |
|
|
|
|
||||||||||||||||||||||
|
Total Investments Reported at Fair Value Using NAV
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Asset Class | Investment Category Includes | |||||||
| Mezzanine Debt | Funds with investments in junior or subordinated debt and potentially minority equity securities issued by private companies. | |||||||
| Senior Debt | Funds with investments in senior or first lien debt and potentially minority equity securities typically issued by private companies. | |||||||
| Distressed Debt |
Funds with debt or minority equity investments that are made opportunistically in companies that are in or near default or under financial strain with potential to have an active role in restructuring the company.
|
|||||||
| Secondary Transactions | Funds that focus on purchasing third party fund interests from investors seeking liquidity within their own portfolio. | |||||||
| Hedge Fund | Funds that focus primarily on investing in public securities with strategy of generating uncorrelated returns to the public markets. | |||||||
| Leveraged Buyout | Funds with control equity investments in more mature, positive cash flowing, private companies that are typically purchased with the use of financial leverage. | |||||||
| Growth Equity |
Funds that invest in early or venture stage companies with high growth potential with view towards generating realizations through sale or initial public offering of company.
|
|||||||
| Real Estate | Funds with investments in multi-family housing properties. | |||||||
| Other | Consists of direct investments of preferred equity or minority common equity investments into private companies structured as limited partnerships or limited liability companies. | |||||||
| September 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||
| (Dollars in Millions) | Level | Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||||||||||||||||
| Financial Assets: | ||||||||||||||||||||||||||||||||
| Loans to Policyholders | Level 3 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Short-term Investments | Level 1 or 2 |
|
|
|
|
|||||||||||||||||||||||||||
| Mortgage Loans | Level 3 |
|
|
|
|
|||||||||||||||||||||||||||
| Company-Owned Life Insurance | Level 2 |
|
|
|
|
|||||||||||||||||||||||||||
| Equity Securities at Modified Cost | Level 3 |
|
|
|
|
|||||||||||||||||||||||||||
| Financial Liabilities: | ||||||||||||||||||||||||||||||||
| Long-term Debt | Level 2 | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Policyholder Obligations | Level 2 |
|
|
|
|
|||||||||||||||||||||||||||
|
(Dollars in Millions)
|
Specialty
|
Life |
Segment Total
|
Non-Core Operations | Total | |||||||||||||||||||||||||||
|
Balance, December 31, 2024
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Capitalizations |
|
|
|
|
|
|||||||||||||||||||||||||||
|
Amortization Expense
2
|
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
|
Balance, September 30, 2025
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Includes $
|
||||||||||||||||||||||||||||||||
|
2
Includes $
|
||||||||||||||||||||||||||||||||
|
(Dollars in Millions)
|
Specialty | Life |
Segment Total
|
Non-Core Operations | Total | |||||||||||||||||||||||||||
|
Balance, December 31, 2023
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Capitalizations |
|
|
|
|
|
|||||||||||||||||||||||||||
|
Amortization Expense
|
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
|
Balance, September 30, 2024
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Includes $
|
||||||||||||||||||||||||||||||||
|
Three Months Ended September 30, 2025
|
||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Specialty | Life | Total Segments | Non-Core Operations | Total Allowance for Expected Credit Losses | |||||||||||||||||||||||||||
| Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Provision for Expected Credit Losses |
|
|
|
|
|
|||||||||||||||||||||||||||
| Write-offs of Uncollectible Receivables from Policyholders |
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
Receivable Balance, End of Period
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Specialty, Total Segments, and Total Includes $
|
||||||||||||||||||||||||||||||||
|
Three Months Ended September 30, 2024
|
||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Specialty | Life | Total Segments | Non-Core Operations | Total Allowance for Expected Credit Losses | |||||||||||||||||||||||||||
| Balance, Beginning of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Provision for Expected Credit Losses |
|
|
|
|
|
|||||||||||||||||||||||||||
| Write-offs of Uncollectible Receivables from Policyholders |
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
Receivable Balance, End of Period
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Specialty, Total Segments, and Total Includes $
|
||||||||||||||||||||||||||||||||
|
Nine Months Ended September 30, 2025
|
||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Specialty | Life | Total Segments | Non-Core Operations | Total Allowance for Expected Credit Losses | |||||||||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Provision for Expected Credit Losses |
|
|
|
|
|
|||||||||||||||||||||||||||
| Write-offs of Uncollectible Receivables from Policyholders |
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
Receivable Balance, End of Period
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Specialty, Total Segments, and Total Includes $
|
||||||||||||||||||||||||||||||||
|
Nine Months Ended September 30, 2024
|
||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Specialty | Life | Total Segments | Non-Core Operations | Total Allowance for Expected Credit Losses | |||||||||||||||||||||||||||
| Balance, Beginning of Year | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
| Provision for Expected Credit Losses |
|
|
|
|
|
|||||||||||||||||||||||||||
| Write-offs of Uncollectible Receivables from Policyholders |
(
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Balance, End of Period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
Receivable Balance, End of Period
1
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
|
1
Specialty, Total Segments, and Total Includes $
|
||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Net Unrealized Losses on Fixed Maturities
|
Net Unrealized Losses on Investments with an Allowance for Credit Losses
|
Net Unrecognized Postretirement Benefit Income | Net Loss on Cash Flow Hedges | Change in Discount Rate on Future Life Policyholder Benefits | Total | ||||||||||||||||||||||||||||||||
| Balance as of June 30, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Other Comprehensive Income (Loss) Before Reclassifications |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
|
Amounts Reclassified from Accumulated Other Comprehensive Loss Net of Tax Expense of $
|
|
|
(
|
(
|
|
|
||||||||||||||||||||||||||||||||
|
Other Comprehensive Income (Loss) Net of Tax Expense (Benefit) of $
|
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Balance as of September 30, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| (Dollars in Millions) |
Net Unrealized Losses on Fixed Maturities
|
Net Unrealized Losses on Investments with an Allowance for Credit Losses
|
Net Unrecognized Postretirement Benefit Costs | Net (Loss) Gain on Cash Flow Hedges | Change in Discount Rate on Future Life Policyholder Benefits | Total | ||||||||||||||||||||||||||||||||
| Balance as of June 30, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Other Comprehensive Income (Loss) Before Reclassifications |
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
|
Amounts Reclassified from Accumulated Other Comprehensive Loss Net of Tax (Benefit) Expense of $
|
|
|
(
|
|
|
(
|
||||||||||||||||||||||||||||||||
|
Other Comprehensive Income (Loss) Net of Tax Expense (Benefit) of $
|
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Balance as of September 30, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| (Dollars in Millions) |
Net Unrealized Losses on Fixed Maturities
|
Net Unrealized Losses on Investments with an Allowance for Credit Losses
|
Net Unrecognized Postretirement Benefit Income | Net Loss on Cash Flow Hedges | Change in Discount Rate on Future Life Policyholder Benefits | Total | ||||||||||||||||||||||||||||||||
| Balance as of January 1, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
(
|
|||||||||||||||||||||||||||
| Other Comprehensive Income (Loss) Before Reclassifications |
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||
|
Amounts Reclassified from Accumulated Other Comprehensive Loss Net of Tax Expense (Benefit) of $
|
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
|
Other Comprehensive Income (Loss) Net of Tax Expense (Benefit) of $
|
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Balance as of September 30, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| (Dollars in Millions) |
Net Unrealized Losses on Fixed Maturities
|
Net Unrealized Losses on Investments with an Allowance for Credit Losses
|
Net Unrecognized Postretirement Benefit Costs | Net Gain on Cash Flow Hedges | Change in Discount Rate on Future Life Policyholder Benefits | Total | ||||||||||||||||||||||||||||||||
| Balance as of January 1, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Other Comprehensive Income (Loss) Before Reclassifications |
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
Amounts Reclassified from Accumulated Other Comprehensive Loss Net of Tax Expense (Benefit) of $
|
|
(
|
(
|
|
|
|
||||||||||||||||||||||||||||||||
|
Other Comprehensive Income (Loss) Net of Tax Expense (Benefit) of $
|
|
(
|
(
|
|
|
|
||||||||||||||||||||||||||||||||
| Balance as of September 30, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Components of AOCI |
Condensed Consolidated Statements of (Loss) Income Line Item Affected by Reclassifications
|
||||
|
Net Unrealized Losses on Fixed Maturities
|
Net Realized Investment Gains
|
||||
|
Net Unrealized Losses on Investments with an Allowance for Credit Losses
|
Impairment Losses and Net Realized Investment Gains
|
||||
|
Net Unrecognized Postretirement Benefit Costs
|
Policyholders’ Benefits and Incurred Losses and Loss Adjustment Expenses, Insurance and Other Expenses, and Interest Expense
|
||||
|
Net (Loss) Gain on Cash Flow Hedges
|
Net Investment Income and Interest Expense
|
||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
|
(Dollars in Millions)
|
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Specialty Property & Casualty Insurance | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Life Insurance |
|
|
|
|
||||||||||||||||||||||
|
Total Segment Amortization Expense
|
|
|
|
|
||||||||||||||||||||||
|
Corporate and Other
|
|
|
|
|
||||||||||||||||||||||
|
Non-Core Operations
1
|
|
|
|
|
||||||||||||||||||||||
|
Total Amortization Expense
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
During the three and nine months ended September 30, 2025, the Company recognized a $
|
||||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| FHLB Funding Agreements | $ |
|
$ |
|
||||||||||
| Universal Life-type Policyholder Account Balances |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Liability under Funding Agreements | $ |
|
$ |
|
||||||||||
| Fair Value of Collateral Pledged |
|
|
||||||||||||
| FHLB of Chicago Common Stock Owned at Cost |
|
|
||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Senior Notes: | ||||||||||||||
| Current: | ||||||||||||||
|
|
$ |
|
$ |
|
||||||||||
| Non-Current: | ||||||||||||||
|
|
|
|
||||||||||||
|
|
|
|
||||||||||||
|
|
|
|
||||||||||||
| Total Long-term Debt Outstanding | $ |
|
$ |
|
||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Operating Lease Right-of-Use Assets | $ |
|
$ |
|
||||||||||
| Operating Lease Liabilities |
|
|
||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Lease Cost: | ||||||||||||||||||||||||||
| Operating Lease Cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Variable Lease Cost |
|
|
|
|
||||||||||||||||||||||
|
Short-Term Lease Cost
1
|
|
|
|
|
||||||||||||||||||||||
|
Total Lease Cost
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
1
Leases with an initial term of twelve months or less are not recorded on the Condensed Consolidated Balance Sheets.
|
||||||||||||||||||||||||||
| Nine Months Ended | ||||||||||||||
|
Sep 30,
2025 |
Sep 30,
2024 |
|||||||||||||
| Weighted-average Remaining Lease Term - Operating Leases |
|
|
||||||||||||
| Weighted-average Discount Rate - Operating Leases |
|
% |
|
% | ||||||||||
| (Dollars in Millions) | September 30, 2025 | |||||||
|
Remainder of 2025
|
$ |
|
||||||
| 2026 |
|
|||||||
| 2027 |
|
|||||||
| 2028 |
|
|||||||
| 2029 |
|
|||||||
| 2030 and Thereafter |
|
|||||||
| Total Future Payments | $ |
|
||||||
| Less: Discount |
|
|||||||
| Present Value of Minimum Lease Payments | $ |
|
||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Change |
Sep 30,
2025 |
Sep 30,
2024 |
Change | ||||||||||||||||||||||||||||||||
|
Net (Loss) Income attributable to Kemper Corporation
|
$ | (21.0) | $ | 73.7 | $ | (94.7) | $ | 151.3 | $ | 220.4 | $ | (69.1) | ||||||||||||||||||||||||||
| Less: | ||||||||||||||||||||||||||||||||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
(1.7) | (1.8) | 0.1 | (2.0) | (0.1) | (1.9) | ||||||||||||||||||||||||||||||||
| Net Realized Investment Gains | 3.1 | 0.9 | 2.2 | 3.7 | 7.3 | (3.6) | ||||||||||||||||||||||||||||||||
| Impairment Losses | (2.5) | (1.7) | (0.8) | (5.1) | (3.0) | (2.1) | ||||||||||||||||||||||||||||||||
| Acquisition and Disposition Related Transaction, Integration, Restructuring and Other Costs | (19.6) | (9.1) | (10.5) | (27.6) | (24.3) | (3.3) | ||||||||||||||||||||||||||||||||
| Debt Extinguishment, Pension Settlement, and Other Charges | — | (2.2) | 2.2 | 0.4 | (0.1) | 0.5 | ||||||||||||||||||||||||||||||||
| Non-Core Operations | (20.7) | (17.4) | (3.3) | (29.0) | (25.8) | (3.2) | ||||||||||||||||||||||||||||||||
| Adjusted Consolidated Net Operating Income | $ | 20.4 | $ | 105.0 | $ | (84.6) | $ | 210.9 | $ | 266.4 | $ | (55.5) | ||||||||||||||||||||||||||
|
Components of Adjusted Consolidated Net Operating Income:
|
||||||||||||||||||||||||||||||||||||||
|
Segment Adjusted Net Operating Income:
|
||||||||||||||||||||||||||||||||||||||
| Specialty Property & Casualty Insurance | $ | 7.6 | $ | 103.6 | $ | (96.0) | $ | 184.5 | $ | 275.1 | $ | (90.6) | ||||||||||||||||||||||||||
| Life Insurance | 18.6 | 15.0 | 3.6 | 48.4 | 26.7 | 21.7 | ||||||||||||||||||||||||||||||||
|
Total Segment Adjusted Net Operating Income
|
26.2 | 118.6 | (92.4) | 232.9 | 301.8 | (68.9) | ||||||||||||||||||||||||||||||||
| Corporate and Other Adjusted Net Operating Loss | (9.0) | (15.1) | 6.1 | (30.7) | (39.0) | 8.3 | ||||||||||||||||||||||||||||||||
| Less: Net Loss attributable to Noncontrolling Interest | (3.2) | (1.5) | (1.7) | (8.7) | (3.6) | (5.1) | ||||||||||||||||||||||||||||||||
| Adjusted Consolidated Net Operating Income | $ | 20.4 | $ | 105.0 | $ | (84.6) | $ | 210.9 | $ | 266.4 | $ | (55.5) | ||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Net Premiums Written | $ | 982.2 | $ | 938.0 | $ | 3,052.5 | $ | 2,736.5 | ||||||||||||||||||
| Earned Premiums | $ | 1,017.3 | $ | 919.0 | $ | 2,990.3 | $ | 2,621.6 | ||||||||||||||||||
| Net Investment Income | 53.8 | 52.0 | 153.9 | 139.7 | ||||||||||||||||||||||
| Other Income | 2.5 | 1.6 | 6.5 | 4.6 | ||||||||||||||||||||||
| Total Revenues | 1,073.6 | 972.6 | 3,150.7 | 2,765.9 | ||||||||||||||||||||||
| Incurred Losses and LAE related to: | ||||||||||||||||||||||||||
| Current Year: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | 798.7 | 644.2 | 2,211.1 | 1,846.0 | ||||||||||||||||||||||
| Catastrophe Losses and LAE | 1.0 | 3.6 | 10.1 | 18.0 | ||||||||||||||||||||||
| Prior Years: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | 51.4 | (0.1) | 65.5 | 4.4 | ||||||||||||||||||||||
| Catastrophe Losses and LAE | — | 0.2 | 0.6 | 0.8 | ||||||||||||||||||||||
| Total Incurred Losses and LAE | 851.1 | 647.9 | 2,287.3 | 1,869.2 | ||||||||||||||||||||||
| Insurance Expenses | 214.6 | 194.9 | 634.5 | 552.5 | ||||||||||||||||||||||
|
Segment Adjusted Operating Income
|
7.9 | 129.8 | 228.9 | 344.2 | ||||||||||||||||||||||
| Income Tax Expense | 0.3 | 26.2 | 44.4 | 69.1 | ||||||||||||||||||||||
| Total Segment Adjusted Net Operating Income | $ | 7.6 | $ | 103.6 | $ | 184.5 | $ | 275.1 | ||||||||||||||||||
| Ratios Based On Earned Premiums | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 78.5 | % | 70.1 | % | 74.0 | % | 70.4 | % | ||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.1 | 0.4 | 0.3 | 0.7 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 5.1 | — | 2.2 | 0.2 | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | — | — | — | ||||||||||||||||||||||
| Total Incurred Loss and LAE Ratio | 83.7 | 70.5 | 76.5 | 71.3 | ||||||||||||||||||||||
| Insurance Expense Ratio | 21.1 | 21.2 | 21.2 | 21.1 | ||||||||||||||||||||||
| Combined Ratio | 104.8 | % | 91.7 | % | 97.7 | % | 92.4 | % | ||||||||||||||||||
| Underlying Combined Ratio | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 78.5 | % | 70.1 | % | 74.0 | % | 70.4 | % | ||||||||||||||||||
| Insurance Expense Ratio | 21.1 | 21.2 | 21.2 | 21.1 | ||||||||||||||||||||||
| Underlying Combined Ratio | 99.6 | % | 91.3 | % | 95.2 | % | 91.5 | % | ||||||||||||||||||
| Non-GAAP Measure Reconciliation | ||||||||||||||||||||||||||
| Combined Ratio | 104.8 | % | 91.7 | % | 97.7 | % | 92.4 | % | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.1 | 0.4 | 0.3 | 0.7 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 5.1 | — | 2.2 | 0.2 | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | — | — | — | ||||||||||||||||||||||
| Underlying Combined Ratio | 99.6 | % | 91.3 | % | 95.2 | % | 91.5 | % | ||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Insurance Reserves: | ||||||||||||||
| Personal Automobile | $ | 1,752.1 | $ | 1,626.0 | ||||||||||
| Commercial Automobile | 894.2 | 721.9 | ||||||||||||
| Total Insurance Reserves | $ | 2,646.3 | $ | 2,347.9 | ||||||||||
| Insurance Reserves: | ||||||||||||||
| Loss and Allocated LAE Reserves: | ||||||||||||||
| Case and Allocated LAE | $ | 932.7 | $ | 921.8 | ||||||||||
| Incurred But Not Reported | 1,518.7 | 1,250.6 | ||||||||||||
| Total Loss and LAE Reserves | 2,451.4 | 2,172.4 | ||||||||||||
| Unallocated LAE Reserves | 194.9 | 175.5 | ||||||||||||
| Total Insurance Reserves | $ | 2,646.3 | $ | 2,347.9 | ||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Net Premiums Written | $ | 727.6 | $ | 735.1 | $ | 2,318.5 | $ | 2,147.1 | ||||||||||||||||||
| Earned Premiums | $ | 785.1 | $ | 731.3 | $ | 2,328.1 | $ | 2,098.1 | ||||||||||||||||||
| Incurred Losses and LAE related to: | ||||||||||||||||||||||||||
| Current Year: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | $ | 629.2 | $ | 507.8 | $ | 1,729.3 | $ | 1,465.1 | ||||||||||||||||||
| Catastrophe Losses and LAE | 0.6 | 2.1 | 7.6 | 13.5 | ||||||||||||||||||||||
| Prior Years: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | 8.0 | (2.7) | (1.7) | 4.4 | ||||||||||||||||||||||
| Catastrophe Losses and LAE | (0.1) | 0.1 | 0.3 | 0.7 | ||||||||||||||||||||||
| Total Incurred Losses and LAE | $ | 637.7 | $ | 507.3 | $ | 1,735.5 | $ | 1,483.7 | ||||||||||||||||||
| Ratios Based On Earned Premiums | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 80.1 | % | 69.5 | % | 74.3 | % | 69.9 | % | ||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.1 | 0.3 | 0.3 | 0.6 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 1.0 | (0.4) | (0.1) | 0.2 | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | — | — | — | ||||||||||||||||||||||
| Total Incurred Loss and LAE Ratio | 81.2 | 69.4 | 74.5 | 70.7 | ||||||||||||||||||||||
| Insurance Expense Ratio | 22.0 | 21.7 | 22.0 | 21.6 | ||||||||||||||||||||||
| Combined Ratio | 103.2 | % | 91.1 | % | 96.5 | % | 92.3 | % | ||||||||||||||||||
| Underlying Combined Ratio | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 80.1 | % | 69.5 | % | 74.3 | % | 69.9 | % | ||||||||||||||||||
| Insurance Expense Ratio | 22.0 | 21.7 | 22.0 | 21.6 | ||||||||||||||||||||||
| Underlying Combined Ratio | 102.1 | % | 91.2 | % | 96.3 | % | 91.5 | % | ||||||||||||||||||
| Non-GAAP Measure Reconciliation | ||||||||||||||||||||||||||
| Combined Ratio | 103.2 | % | 91.1 | % | 96.5 | % | 92.3 | % | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.1 | 0.3 | 0.3 | 0.6 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 1.0 | (0.4) | (0.1) | 0.2 | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | — | — | — | ||||||||||||||||||||||
| Underlying Combined Ratio | 102.1 | % | 91.2 | % | 96.3 | % | 91.5 | % | ||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Net Premiums Written | $ | 254.6 | $ | 202.9 | $ | 734.0 | $ | 589.4 | ||||||||||||||||||
| Earned Premiums | $ | 232.2 | $ | 187.7 | $ | 662.2 | $ | 523.5 | ||||||||||||||||||
| Incurred Losses and LAE related to: | ||||||||||||||||||||||||||
| Current Year: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | $ | 169.5 | $ | 136.4 | $ | 481.8 | $ | 380.9 | ||||||||||||||||||
| Catastrophe Losses and LAE | 0.4 | 1.5 | 2.5 | 4.5 | ||||||||||||||||||||||
| Prior Years: | ||||||||||||||||||||||||||
| Non-catastrophe Losses and LAE | 43.4 | 2.6 | 67.2 | — | ||||||||||||||||||||||
| Catastrophe Losses and LAE | 0.1 | 0.1 | 0.3 | 0.1 | ||||||||||||||||||||||
| Total Incurred Losses and LAE | $ | 213.4 | $ | 140.6 | $ | 551.8 | $ | 385.5 | ||||||||||||||||||
| Ratios Based On Earned Premiums | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 73.0 | % | 72.6 | % | 72.8 | % | 72.7 | % | ||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.2 | 0.8 | 0.4 | 0.9 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 18.7 | 1.4 | 10.1 | — | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | 0.1 | — | — | ||||||||||||||||||||||
| Total Incurred Loss and LAE Ratio | 91.9 | 74.9 | 83.3 | 73.6 | ||||||||||||||||||||||
| Insurance Expense Ratio | 18.1 | 19.2 | 18.3 | 19.1 | ||||||||||||||||||||||
| Combined Ratio | 110.0 | % | 94.1 | % | 101.6 | % | 92.7 | % | ||||||||||||||||||
| Underlying Combined Ratio | ||||||||||||||||||||||||||
| Current Year Non-catastrophe Losses and LAE Ratio | 73.0 | % | 72.6 | % | 72.8 | % | 72.7 | % | ||||||||||||||||||
| Insurance Expense Ratio | 18.1 | 19.2 | 18.3 | 19.1 | ||||||||||||||||||||||
| Underlying Combined Ratio | 91.1 | % | 91.8 | % | 91.1 | % | 91.8 | % | ||||||||||||||||||
| Non-GAAP Measure Reconciliation | ||||||||||||||||||||||||||
| Combined Ratio | 110.0 | % | 94.1 | % | 101.6 | % | 92.7 | % | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Current Year Catastrophe Losses and LAE Ratio | 0.2 | 0.8 | 0.4 | 0.9 | ||||||||||||||||||||||
| Prior Years Non-catastrophe Losses and LAE Ratio | 18.7 | 1.4 | 10.1 | — | ||||||||||||||||||||||
| Prior Years Catastrophe Losses and LAE Ratio | — | 0.1 | — | — | ||||||||||||||||||||||
| Underlying Combined Ratio | 91.1 | % | 91.8 | % | 91.1 | % | 91.8 | % | ||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
|
Earned Premiums
|
$ | 99.8 | $ | 100.6 | $ | 300.0 | $ | 298.7 | ||||||||||||||||||
| Net Investment Income | 48.0 | 50.3 | 141.1 | 125.1 | ||||||||||||||||||||||
| Other Income | 0.4 | 0.2 | 1.4 | 0.7 | ||||||||||||||||||||||
| Total Revenues | 148.2 | 151.1 | 442.5 | 424.5 | ||||||||||||||||||||||
|
Policyholders’ Benefits and Incurred Losses and LAE
|
60.5 | 64.1 | 186.2 | 191.0 | ||||||||||||||||||||||
| Insurance Expenses | 65.6 | 69.0 | 199.7 | 202.9 | ||||||||||||||||||||||
| Segment Adjusted Operating Income | 22.1 | 18.0 | 56.6 | 30.6 | ||||||||||||||||||||||
| Income Tax Expense | 3.5 | 3.0 | 8.2 | 3.9 | ||||||||||||||||||||||
| Total Segment Adjusted Net Operating Income | $ | 18.6 | $ | 15.0 | $ | 48.4 | $ | 26.7 | ||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Insurance Reserves: | ||||||||||||||
| Future Policyholder Benefits | $ | 3,282.2 | $ | 3,154.3 | ||||||||||
| Incurred Losses and LAE Reserves: | ||||||||||||||
| Life | 31.1 | 40.8 | ||||||||||||
| Accident and Health | 4.3 | 4.6 | ||||||||||||
| Property | 2.0 | 2.7 | ||||||||||||
| Total Incurred Losses and LAE Reserves | 37.4 | 48.1 | ||||||||||||
| Total Insurance Reserves | $ | 3,319.6 | $ | 3,202.4 | ||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Investment Income: | ||||||||||||||||||||||||||
|
Interest on Fixed Maturities
1
|
$ | 79.1 | $ | 79.0 | $ | 232.4 | $ | 239.0 | ||||||||||||||||||
| Dividends on Equity Securities Excluding Alternative Investments | 2.1 | 0.9 | 3.6 | 4.6 | ||||||||||||||||||||||
| Alternative Investments: | ||||||||||||||||||||||||||
| Equity Method Limited Liability Investments | — | 0.9 | (6.0) | (15.9) | ||||||||||||||||||||||
| Limited Liability Investments Included in Equity Securities | 4.0 | 9.1 | 10.8 | 18.7 | ||||||||||||||||||||||
| Total Alternative Investments | 4.0 | 10.0 | 4.8 | 2.8 | ||||||||||||||||||||||
| Short-term Investments | 4.2 | 8.4 | 18.8 | 23.0 | ||||||||||||||||||||||
| Loans to Policyholders | 5.2 | 5.5 | 15.6 | 15.8 | ||||||||||||||||||||||
| Real Estate | 2.5 | 2.2 | 7.0 | 6.7 | ||||||||||||||||||||||
|
Company-Owned Life Insurance
|
10.8 | 9.7 | 31.5 | 25.7 | ||||||||||||||||||||||
| Other | 3.1 | 2.2 | 8.4 | 7.3 | ||||||||||||||||||||||
| Total Investment Income | 111.0 | 117.9 | 322.1 | 324.9 | ||||||||||||||||||||||
| Investment Expenses: | ||||||||||||||||||||||||||
| Real Estate | 2.0 | 1.8 | 6.3 | 6.1 | ||||||||||||||||||||||
|
Other Investment Expenses
|
4.2 | 5.0 | 13.9 | 14.3 | ||||||||||||||||||||||
| Total Investment Expenses | 6.2 | 6.8 | 20.2 | 20.4 | ||||||||||||||||||||||
| Net Investment Income | $ | 104.8 | $ | 111.1 | $ | 301.9 | $ | 304.5 | ||||||||||||||||||
|
1
Reduced by interest expense incurred on FHLB borrowings used for spread lending purposes of $4.7 million and $4.8 million for the three months ended September 30, 2025 and 2024, respectively, and $14.3 million and $15.4 million for the nine months ended September 30, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Preferred Stocks | $ | (0.5) | $ | 0.7 | $ | — | $ | 1.1 | ||||||||||||||||||
| Common Stocks | (0.1) | (0.4) | 0.6 | 1.2 | ||||||||||||||||||||||
| Other Equity Interests: | ||||||||||||||||||||||||||
| Limited Liability Companies and Limited Partnerships | (1.5) | (2.6) | (3.1) | (2.4) | ||||||||||||||||||||||
| Total Other Equity Interests | (1.5) | (2.6) | (3.1) | (2.4) | ||||||||||||||||||||||
| Change in Fair Value of Equity Securities | (2.1) | (2.3) | (2.5) | (0.1) | ||||||||||||||||||||||
|
Change in Fair Value of Convertible Securities
|
— | — | — | — | ||||||||||||||||||||||
|
Change in Fair Value of Equity and Convertible Securities
|
$ | (2.1) | $ | (2.3) | $ | (2.5) | $ | (0.1) | ||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||||||||
| Gains on Sales | $ | 3.7 | $ | 0.9 | $ | 5.4 | $ | 15.9 | ||||||||||||||||||
| Losses on Sales | (0.5) | — | (1.5) | (2.6) | ||||||||||||||||||||||
|
Losses on Hedging Activity
1
|
— | — | — | (7.9) | ||||||||||||||||||||||
| Equity Securities: | ||||||||||||||||||||||||||
| Gains on Sales | 0.5 | — | 0.5 | 4.1 | ||||||||||||||||||||||
| Losses on Sales | — | — | — | (0.1) | ||||||||||||||||||||||
|
Other Investments:
|
||||||||||||||||||||||||||
| Gains on Sales | 0.2 | 1.8 | 0.3 | 3.3 | ||||||||||||||||||||||
| Losses on Sales | — | (1.6) | — | (3.5) | ||||||||||||||||||||||
|
Net Realized Investment Gains
|
$ | 3.9 | $ | 1.1 | $ | 4.7 | $ | 9.2 | ||||||||||||||||||
| Gross Gains on Sales | $ | 4.4 | $ | 2.7 | $ | 6.2 | $ | 23.3 | ||||||||||||||||||
| Gross Losses on Sales | (0.5) | (1.6) | (1.5) | (6.2) | ||||||||||||||||||||||
| Gains (Losses) on Hedging Activity | — | — | — | (7.9) | ||||||||||||||||||||||
|
Net Realized Investment Gains
|
$ | 3.9 | $ | 1.1 | $ | 4.7 | $ | 9.2 | ||||||||||||||||||
|
1
Includes Ultra-Long Treasury Future derivative securities which do not qualify for hedge accounting treatment.
|
||||||||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2025 | Sep 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Amount | Number of Issuers | Amount | Number of Issuers | Amount | Number of Issuers |
Amount
|
Number of Issuers | ||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities | $ | (2.9) | 22 | $ | (2.0) | 16 | $ | (6.2) | 23 | $ | (2.8) | 19 | ||||||||||||||||||||||||||||||||||||||
| Equity Securities at Modified Cost | — | — | — | — | — | — | (0.4) | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Real Estate | (0.1) | 4 | (0.2) | 4 | (0.1) | 4 | (0.3) | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Other | (0.1) | 5 | — | — | (0.1) | 5 | (0.3) | 1 | ||||||||||||||||||||||||||||||||||||||||||
|
Impairment Losses
1
|
$ | (3.1) | $ | (2.2) | $ | (6.4) | $ | (3.8) | ||||||||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Dec 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||
|
NAIC
Rating |
Rating | Amortized Cost | Fair Value | Percentage of Total | Amortized Cost | Fair Value | Percentage of Total | |||||||||||||||||||||||||||||||||||||
| 1 | AAA, AA, A | $ | 5,244.5 | $ | 4,685.2 | 70.8 | % | $ | 5,253.1 | $ | 4,576.4 | 71.4 | % | |||||||||||||||||||||||||||||||
| 2 | BBB | 1,674.4 | 1,542.6 | 23.3 | 1,749.3 | 1,557.6 | 24.3 | |||||||||||||||||||||||||||||||||||||
| 3-4 | BB, B | 361.4 | 349.7 | 5.3 | 233.0 | 221.7 | 3.5 | |||||||||||||||||||||||||||||||||||||
| 5-6 | CCC or Lower | 51.4 | 42.8 | 0.6 | 59.6 | 53.9 | 0.8 | |||||||||||||||||||||||||||||||||||||
| Total Investments in Fixed Maturities | $ | 7,331.7 | $ | 6,620.3 | 100.0 | % | $ | 7,295.0 | $ | 6,409.6 | 100.0 | % | ||||||||||||||||||||||||||||||||
| Sep 30, 2025 | Dec 31, 2024 | |||||||||||||||||||||||||
| (Dollars in Millions) | Fair Value |
Percentage
of Total Investments |
Fair Value |
Percentage
of Total Investments |
||||||||||||||||||||||
| U.S. Government and Government Agencies and Authorities | $ | 592.1 | 6.9 | % | $ | 486.8 | 5.5 | % | ||||||||||||||||||
| States and Political Subdivisions: | ||||||||||||||||||||||||||
| Revenue Bonds | 1,092.6 | 12.7 | 1,105.7 | 12.4 | ||||||||||||||||||||||
| States | 94.9 | 1.1 | 72.4 | 0.8 | ||||||||||||||||||||||
| Political Subdivisions | 55.7 | 0.6 | 55.1 | 0.6 | ||||||||||||||||||||||
| Foreign Governments | 12.0 | 0.1 | 6.6 | 0.1 | ||||||||||||||||||||||
| Total Investments in Governmental Fixed Maturities | $ | 1,847.3 | 21.4 | % | $ | 1,726.6 | 19.4 | % | ||||||||||||||||||
| Sep 30, 2025 | Dec 31, 2024 | |||||||||||||||||||||||||
| (Dollars in Millions) | Fair Value |
Percentage
of Total Investments |
Fair Value |
Percentage
of Total Investments |
||||||||||||||||||||||
| Finance, Insurance and Real Estate | $ | 2,040.4 | 23.7 | % | $ | 1,969.1 | 22.2 | % | ||||||||||||||||||
| Manufacturing | 974.7 | 11.3 | 1,014.3 | 11.4 | ||||||||||||||||||||||
| Transportation, Communication and Utilities | 838.2 | 9.7 | 793.0 | 8.9 | ||||||||||||||||||||||
| Services | 610.5 | 7.1 | 582.9 | 6.6 | ||||||||||||||||||||||
| Mining | 164.7 | 1.9 | 153.3 | 1.7 | ||||||||||||||||||||||
| Retail Trade | 115.8 | 1.3 | 125.7 | 1.4 | ||||||||||||||||||||||
| Construction | 9.8 | 0.1 | 11.7 | 0.1 | ||||||||||||||||||||||
| Other | 36.9 | 0.4 | 33.0 | 0.4 | ||||||||||||||||||||||
| Total Investments in Non-governmental Fixed Maturities | $ | 4,791.0 | 55.5 | % | $ | 4,683.0 | 52.7 | % | ||||||||||||||||||
| (Dollars in Millions) | Number of Issuers | Aggregate Fair Value | ||||||||||||
| Below $5 | 664 | $ | 1,364.0 | |||||||||||
| $5 -$10 | 196 | 1,414.6 | ||||||||||||
| $10 - $20 | 106 | 1,405.1 | ||||||||||||
| $20 - $30 | 17 | 394.1 | ||||||||||||
| Greater Than $30 | 6 | 213.2 | ||||||||||||
| Total | 989 | $ | 4,791.0 | |||||||||||
| (Dollars in Millions) |
Fair
Value |
Percentage
of Total Investments |
||||||||||||||||||
| Fixed Maturities: | ||||||||||||||||||||
| States including their Political Subdivisions: | ||||||||||||||||||||
| California | $ | 134.8 | 1.6 | % | ||||||||||||||||
| Texas | 103.9 | 1.2 | ||||||||||||||||||
| Michigan | 87.6 | 1.0 | ||||||||||||||||||
| Georgia | 68.5 | 0.8 | ||||||||||||||||||
| New York | 61.0 | 0.7 | ||||||||||||||||||
| Florida | 54.4 | 0.6 | ||||||||||||||||||
| Pennsylvania | 47.5 | 0.6 | ||||||||||||||||||
| Virginia | 36.2 | 0.4 | ||||||||||||||||||
| Louisiana | 35.6 | 0.4 | ||||||||||||||||||
| Colorado | 35.2 | 0.4 | ||||||||||||||||||
| Total | $ | 664.7 | 7.7 | % | ||||||||||||||||
| (Dollars in Millions) |
Unfunded
Commitment |
Reported Value | ||||||||||||||||||||||||
| Asset Class |
Sep 30,
2025 |
Sep 30,
2025 |
Dec 31,
2024 |
|||||||||||||||||||||||
| Reported as Equity Method Limited Liability Investments: | ||||||||||||||||||||||||||
| Senior Debt | $ | 64.1 | $ | 19.5 | $ | 19.1 | ||||||||||||||||||||
| Mezzanine Debt | 36.2 | 115.2 | 116.7 | |||||||||||||||||||||||
| Secondary Transactions | 1.6 | 2.7 | 5.5 | |||||||||||||||||||||||
| Leveraged Buyout | 0.6 | 6.5 | 7.5 | |||||||||||||||||||||||
| Real Estate | 0.1 | 24.3 | 27.3 | |||||||||||||||||||||||
| Distressed Debt | — | 1.4 | 4.4 | |||||||||||||||||||||||
| Other | — | 5.3 | 5.8 | |||||||||||||||||||||||
| Total Equity Method Limited Liability Investments | 102.6 | 174.9 | 186.3 | |||||||||||||||||||||||
| Reported as Other Equity Interests at Fair Value: | ||||||||||||||||||||||||||
| Mezzanine Debt | 69.8 | 115.9 | 116.9 | |||||||||||||||||||||||
| Leveraged Buyout | 42.7 | 34.5 | 19.2 | |||||||||||||||||||||||
| Distressed Debt | 15.7 | 11.1 | 11.7 | |||||||||||||||||||||||
| Senior Debt | 6.7 | 26.5 | 26.3 | |||||||||||||||||||||||
| Growth Equity | 5.8 | 10.4 | 7.0 | |||||||||||||||||||||||
| Secondary Transactions | 1.6 | 1.6 | 2.4 | |||||||||||||||||||||||
| Real Estate | 0.2 | 0.1 | — | |||||||||||||||||||||||
| Other | 0.2 | 3.9 | 0.1 | |||||||||||||||||||||||
| Total Reported as Other Equity Interests at Fair Value | 142.7 | 204.0 | 183.6 | |||||||||||||||||||||||
|
Reported as Other Investments:
|
||||||||||||||||||||||||||
|
Alternative Energy Partnership Investments
|
— | 17.4 | 17.6 | |||||||||||||||||||||||
|
Equity Securities at Modified Cost
|
0.1 | 1.8 | 1.8 | |||||||||||||||||||||||
|
Total Reported as Other Investments
|
0.1 | 19.2 | 19.4 | |||||||||||||||||||||||
| Total Investments in Limited Liability Companies and Limited Partnerships | $ | 245.4 | $ | 398.1 | $ | 389.3 | ||||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
|
(Dollars in Millions)
|
Sep 30,
2025 |
Sep 30,
2024 |
Sep 30,
2025 |
Sep 30,
2024 |
||||||||||||||||||||||
| Insurance and Other Expenses: | ||||||||||||||||||||||||||
| Insurance Expenses: | ||||||||||||||||||||||||||
|
Policy Acquisition Costs
|
$ | 173.8 | $ | 161.4 | $ | 515.2 | $ | 475.4 | ||||||||||||||||||
| Business Unit Operating Costs | 94.2 | 72.8 | 240.7 | 201.1 | ||||||||||||||||||||||
|
Corporate Overhead Costs
|
43.7 | 49.2 | 135.0 | 147.4 | ||||||||||||||||||||||
| Insurance Expenses | 311.7 | 283.4 | 890.9 | 823.9 | ||||||||||||||||||||||
| Other Expenses: | ||||||||||||||||||||||||||
| Acquisition and Disposition Related Transaction, Integration, Restructuring and Other Costs | 22.9 | 11.5 | 33.0 | 30.8 | ||||||||||||||||||||||
| Pension Settlement | — | 0.1 | — | (2.6) | ||||||||||||||||||||||
| Other Corporate Costs | 4.5 | 9.4 | 9.7 | 18.4 | ||||||||||||||||||||||
| Other Expenses | 27.4 | 21.0 | 42.7 | 46.6 | ||||||||||||||||||||||
| Insurance and Other Expenses | 339.1 | 304.4 | 933.6 | 870.5 | ||||||||||||||||||||||
| Interest Expense | 9.1 | 14.4 | 29.5 | 42.3 | ||||||||||||||||||||||
|
Total Insurance, Interest, and Other Expenses
|
$ | 348.2 | $ | 318.8 | $ | 963.1 | $ | 912.8 | ||||||||||||||||||
| (Dollars in Millions) |
Sep 30,
2025 |
Dec 31,
2024 |
||||||||||||
| Senior Notes: | ||||||||||||||
| Current: | ||||||||||||||
|
4.350%
Senior Notes due February 15, 2025
|
$ | — | $ | 449.9 | ||||||||||
| Non-Current: | ||||||||||||||
|
2.400%
Senior Notes due September 30, 2030
|
397.8 | 397.5 | ||||||||||||
|
3.800%
Senior Notes due February 23, 2032
|
396.8 | 396.5 | ||||||||||||
|
5.875%
Fixed-Rate Reset Junior Subordinated Debentures due 2062
|
148.5 | 147.7 | ||||||||||||
| Total Long-term Debt Outstanding | $ | 943.1 | $ | 1,391.6 | ||||||||||
| (Dollars in Millions) | Sep 30, 2025 | Sep 30, 2024 | ||||||||||||||||||
| Net Cash Provided by Operating Activities | $ | 409.5 | $ | 207.8 | ||||||||||||||||
| Net Cash Provided by (Used in) Investing Activities | 413.4 | (89.6) | ||||||||||||||||||
| Net Cash Used in Financing Activities | (780.9) | (125.4) | ||||||||||||||||||
| Total | Maximum | |||||||||||||||||||||||||
| Number of Shares | Dollar Value of Shares | |||||||||||||||||||||||||
| Average | Purchased as Part | that May Yet Be | ||||||||||||||||||||||||
| Total | Price | of Publicly | Purchased Under | |||||||||||||||||||||||
| Number of Shares | Paid per | Announced Plans | the Plans or Programs | |||||||||||||||||||||||
| Period | Purchased | Share | or Programs | (Dollars in Millions) | ||||||||||||||||||||||
| July 2025 | 833,642 | $ | 62.00 | 833,642 | $ | 48.6 | ||||||||||||||||||||
| August 2025 | 2,572,008 | $ | 52.40 | 2,572,008 | $ | 383.8 | ||||||||||||||||||||
| September 2025 | — | $ | — | — | $ | 383.8 | ||||||||||||||||||||
| Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
| Exhibit Number | Exhibit Description | Form | File Number | Exhibit | Filing Date | Filed or Furnished Herewith | ||||||||||||||||||||||||||||||||
| 10.1 |
X
|
|||||||||||||||||||||||||||||||||||||
| 31.1 | X | |||||||||||||||||||||||||||||||||||||
| 31.2 | X | |||||||||||||||||||||||||||||||||||||
| 32.1 | X | |||||||||||||||||||||||||||||||||||||
| 32.2 | X | |||||||||||||||||||||||||||||||||||||
| 101.1 | XBRL Instance Document | X | ||||||||||||||||||||||||||||||||||||
| 101.2 | XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||||||||||||||||||||
| 101.3 | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
| 101.4 | XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
| 101.5 | XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
| 101.6 | XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | X | ||||||||||||||||||||||||||||||||||||
| Kemper Corporation | ||||||||
| Date: | November 5, 2025 | /s/ C. THOMAS EVANS, JR. | ||||||
|
C. Thomas Evans, Jr.
|
||||||||
|
Interim Chief Executive Officer, Secretary and General Counsel
(Principal Executive Officer)
|
||||||||
| Date: | November 5, 2025 | /s/ BRADLEY T. CAMDEN | ||||||
| Bradley T. Camden | ||||||||
| Executive Vice President and Chief Financial Officer (Principal Financial Officer) | ||||||||
| Date: | November 5, 2025 | /s/ JAMES A. ALEXANDER | ||||||
| James A. Alexander | ||||||||
|
Senior Vice President and Chief Accounting Officer
(Principal Accounting Officer) |
||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| C.H. Robinson Worldwide, Inc. | CHRW |
Suppliers
| Supplier name | Ticker |
|---|---|
| Aon Plc | AON |
| The Hartford Financial Services Group, Inc. | HIG |
| Amgen Inc. | AMGN |
| Bristol-Myers Squibb Company | BMY |
| Fidelity National Information Services, Inc. | FIS |
| AbbVie Inc. | ABBV |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|